Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
May 14, 2020
Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET
May 7, 2020
Applied DNA Receives Approximately $5.3 Million in Net Proceeds from Warrant Exercise
May 6, 2020
Applied DNA Applies to U.S. FDA for Emergency Use Authorization for COVID-19 Diagnostic Kit
May 5, 2020
Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
May 4, 2020
Applied DNA Accepted into U.S. FDA’s Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging
April 30, 2020
High-Sensitivity/Throughput COVID-19 Diagnostic Kit Enters Validation Process
April 21, 2020
Applied DNA Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing
April 15, 2020
Get Social